Werner Meier
38 works · 3,317 citations · h-index 25
Top works
- HIV infection is blocked in vitro by recombinant soluble CD4
- Shedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration
- Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
- Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes
- Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
- Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.
- Low Affinity Interaction of Human or Rat T Cell Adhesion Molecule CD2 with Its Ligand Aligns Adhering Membranes to Achieve High Physiological Affinity
- Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice.
- Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β)
- The crystal structure of human interferon β at 2.2-Å resolution
- Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins and
- Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes
- SHORT COURSE SINGLE AGENT THERAPY WITH AN LFA-3-IgG1 FUSION PROTEIN PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL1,2
- Low affinity binding of an LFA-3/IgG1 fusion protein to CD2+T cells is independent of cell activation
- Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers.
- Targeting the Lymphotoxin-β Receptor with Agonist Antibodies as a Potential Cancer Therapy
- The increased potency of cross-linked lymphocyte function-associated antigen-3 (LFA-3) multimers is a direct consequence of changes in valency.
- Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway
- Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway
- Characterization of trisulfide modification in antibodies